• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新发展理念的治疗盐敏感性高血压的新型抗高血压药物类别

A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

作者信息

Katori Makoto, Majima Masataka

机构信息

Department of Pharmacology, School of Medicine, Kitasato University, Sagamihara, Kanagawa 228-8555, Japan.

出版信息

Pharmaceuticals (Basel). 2010 Jan 7;3(1):59-109. doi: 10.3390/ph3010059.

DOI:10.3390/ph3010059
PMID:27713243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3991021/
Abstract

Terrestrial animals must conserve water and NaCl to survive dry environments. The kidney reabsorbs 95% of the sodium filtered from the glomeruli before sodium reaches the distal connecting tubules. Excess sodium intake requires the renal kallikrein-kinin system for additional excretion. Renal kallikrein is secreted from the distal connecting tubule cells of the kidney, and its substrates, low molecular kininogen, from the principal cells of the cortical collecting ducts (CD). Formed kinins inhibit reabsorption of NaCl through bradykinin (BK)-B₂ receptors, localized along the CD. Degradation pathway of BK by kinin-destroying enzymes in urine differs completely from that in plasma, so that ACE inhibitors are ineffective. Urinary BK is destroyed mainly by a carboxypeptidase-Y-like exopeptidase (CPY) and partly by a neutral endopeptidase (NEP). Inhibitors of CPY and NEP, ebelactone B and poststatin, respectively, were found. Renal kallikrein secretion is accelerated by potassium and ATP-sensitive potassium (K) channel blockers, such as PNU-37883A. Ebelactone B prevents DOCA-salt hypertension in rats. Only high salt intake causes hypertension in animals deficient in BK-B receptors, tissue kallikrein, or kininogen. Hypertensive patients, and spontaneously hypertensive rats, excrete less kallikrein than normal subjects, irrespective of races, and become salt-sensitive. Ebelactone B, poststatin, and K channel blockers could become novel antihypertensive drugs by increase in urinary kinin levels. Roles of kinin in cardiovascular diseases were discussed.

摘要

陆生动物必须保存水分和氯化钠以在干燥环境中生存。在钠到达远曲小管之前,肾脏会重吸收从肾小球滤过的95%的钠。过量的钠摄入需要肾激肽释放酶-激肽系统进行额外排泄。肾激肽释放酶由肾脏的远曲小管细胞分泌,其底物低分子激肽原则来自皮质集合管(CD)的主细胞。生成的激肽通过沿CD分布的缓激肽(BK)-B₂受体抑制氯化钠的重吸收。尿液中激肽破坏酶对BK的降解途径与血浆中的完全不同,因此血管紧张素转换酶抑制剂无效。尿BK主要被一种羧肽酶-Y样外肽酶(CPY)破坏,部分被中性内肽酶(NEP)破坏。分别发现了CPY和NEP的抑制剂依贝内酯B和后他汀。钾和ATP敏感性钾(K)通道阻滞剂,如PNU-37883A,可加速肾激肽释放酶的分泌。依贝内酯B可预防大鼠的去氧皮质酮盐性高血压。只有高盐摄入会导致BK-B受体、组织激肽释放酶或激肽原缺乏的动物患高血压。高血压患者和自发性高血压大鼠,无论种族如何,其激肽释放酶排泄量均低于正常受试者,且对盐敏感。依贝内酯B、后他汀和K通道阻滞剂可通过增加尿激肽水平成为新型抗高血压药物。文中讨论了激肽在心血管疾病中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/8c9ec61aefc4/pharmaceuticals-03-00059-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/16dae5d575af/pharmaceuticals-03-00059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/122971b06e26/pharmaceuticals-03-00059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/4abcd2cae92a/pharmaceuticals-03-00059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/279f82781d92/pharmaceuticals-03-00059-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/cd5d142cf863/pharmaceuticals-03-00059-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/eb9a304c8e06/pharmaceuticals-03-00059-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/d5922ae0fc6c/pharmaceuticals-03-00059-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/8c9ec61aefc4/pharmaceuticals-03-00059-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/16dae5d575af/pharmaceuticals-03-00059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/122971b06e26/pharmaceuticals-03-00059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/4abcd2cae92a/pharmaceuticals-03-00059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/279f82781d92/pharmaceuticals-03-00059-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/cd5d142cf863/pharmaceuticals-03-00059-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/eb9a304c8e06/pharmaceuticals-03-00059-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/d5922ae0fc6c/pharmaceuticals-03-00059-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4e8/3991021/8c9ec61aefc4/pharmaceuticals-03-00059-g008.jpg

相似文献

1
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.基于新发展理念的治疗盐敏感性高血压的新型抗高血压药物类别
Pharmaceuticals (Basel). 2010 Jan 7;3(1):59-109. doi: 10.3390/ph3010059.
2
Renal (tissue) kallikrein-kinin system in the kidney and novel potential drugs for salt-sensitive hypertension.肾脏中的肾(组织)激肽释放酶-激肽系统以及盐敏感性高血压的新型潜在药物。
Prog Drug Res. 2014;69:59-109. doi: 10.1007/978-3-319-06683-7_4.
3
A missing link between a high salt intake and blood pressure increase.高盐摄入与血压升高之间缺失的联系。
J Pharmacol Sci. 2006;100(5):370-90. doi: 10.1254/jphs.crj06003x. Epub 2006 Apr 29.
4
Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.肾激肽释放酶-激肽系统在盐敏感性高血压发生发展中的关键抑制作用。
Biol Res. 1998;31(3):143-9.
5
Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.抑制肾小管管腔侧的激肽降解可降低醋酸脱氧皮质酮盐处理大鼠的高血压。
Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):80-7. doi: 10.1046/j.1440-1681.2000.03209.x.
6
Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.肾激肽释放酶-激肽系统在盐敏感性高血压发生发展中的作用。
Biol Chem. 2001 Jan;382(1):61-4. doi: 10.1515/BC.2001.010.
7
Facilitation of renal kallikrein-kinin system prevents the development of hypertension by inhibition of sodium retention.促进肾激肽释放酶-激肽系统可通过抑制钠潴留来预防高血压的发生。
Immunopharmacology. 1999 Oct 15;44(1-2):145-52. doi: 10.1016/s0162-3109(99)00086-7.
8
Are all individuals equally sensitive in the blood pressure to high salt intake? (Review article).所有人对高盐摄入的血压敏感性都相同吗?(综述文章)
Acta Physiol Hung. 2008 Sep;95(3):247-65. doi: 10.1556/APhysiol.95.2008.3.2.
9
Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship.肾激肽释放酶-激肽系统在高血压发病中的关键作用以及基于此关系的新药研发途径。
Jpn J Pharmacol. 1996 Feb;70(2):95-128. doi: 10.1254/jjp.70.95.
10
Role of the renal kallikrein-kinin system in the development of hypertension.肾激肽释放酶-激肽系统在高血压发生发展中的作用。
Immunopharmacology. 1997 Jun;36(2-3):237-42. doi: 10.1016/s0162-3109(97)00029-5.

引用本文的文献

1
How full is our antihypertensives pipeline?我们的抗高血压药物研发线进展如何?
J Pharmacol Pharmacother. 2012 Jan;3(1):7-11. doi: 10.4103/0976-500X.92492.

本文引用的文献

1
Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2.裂解高分子量激肽原通过抑制基质金属蛋白酶 2 抑制内皮祖细胞的管形成。
J Thromb Haemost. 2010 Jan;8(1):185-93. doi: 10.1111/j.1538-7836.2009.03662.x. Epub 2009 Oct 23.
2
An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.一种 ATP 敏感性钾通道阻滞剂通过增加尿激肽的分泌抑制钠诱导的高血压。
Hypertens Res. 2009 Mar;32(3):220-6. doi: 10.1038/hr.2008.33.
3
Tissue kallikrein deficiency and renovascular hypertension in the mouse.
小鼠组织激肽释放酶缺乏与肾血管性高血压
Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1385-91. doi: 10.1152/ajpregu.90411.2008. Epub 2009 Feb 25.
4
Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.组织激肽释放酶在血管形成和成熟中的关键作用:对治疗性血管再生的意义。
Arterioscler Thromb Vasc Biol. 2009 May;29(5):657-64. doi: 10.1161/ATVBAHA.108.182139. Epub 2009 Jan 22.
5
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential.激肽B2受体信号传导在募集具有血管新生潜力的循环祖细胞中的作用。
Circ Res. 2008 Nov 21;103(11):1335-43. doi: 10.1161/CIRCRESAHA.108.179952. Epub 2008 Oct 16.
6
Are all individuals equally sensitive in the blood pressure to high salt intake? (Review article).所有人对高盐摄入的血压敏感性都相同吗?(综述文章)
Acta Physiol Hung. 2008 Sep;95(3):247-65. doi: 10.1556/APhysiol.95.2008.3.2.
7
Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.组织激肽释放酶通过Akt-糖原合成酶激酶-3β途径促进新生血管形成并改善心脏功能。
Cardiovasc Res. 2008 Dec 1;80(3):354-64. doi: 10.1093/cvr/cvn223. Epub 2008 Aug 9.
8
Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.小鼠急性心肌缺血中的心脏保护与激肽释放酶-激肽系统
Clin Exp Pharmacol Physiol. 2008 Apr;35(4):489-93. doi: 10.1111/j.1440-1681.2008.04902.x.
9
New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.心肌梗死中组织激肽释放酶-激肽系统的新视角:血管生成和心脏再生的作用
Int Immunopharmacol. 2008 Feb;8(2):148-54. doi: 10.1016/j.intimp.2007.07.022. Epub 2007 Aug 17.
10
Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin.缓激肽是一种由蛇毒和胰蛋白酶从血浆球蛋白中释放出来的具有降血压作用和平滑肌刺激作用的因子。
Am J Physiol. 1949 Feb;156(2):261-73. doi: 10.1152/ajplegacy.1949.156.2.261.